The filling line is the real bottleneck for needle-free vaccines

Mucosal vaccines may simplify administration, but commercial success depends on reproducible dosing; container choice, device performance, aseptic processing and line economics will determine scalability

You need to be a subscriber to read this article.
Click here to find out more.

Needle-free vaccines are attracting renewed scientific interest as researchers explore routes that can deliver antigens through mucosal surfaces, including the nose and beneath the tongue.

This approach could simplify administration, improve vaccination acceptance and reduce our dependence on conventional injection-based delivery.

However, translating these formulations into scalable pharmaceutical products introduces a manufacturing challenge that receives less attention than the delivery technology itself: how to fill, close, inspect and package the final dosage form without compromising its biological activity or delivery performance.

Shammi Thakur, Research Director at Vyansa Intelligence, reports.

The filling line is the real bottleneck for needle-free vaccines

The challenge is becoming more relevant following the Medicines and Healthcare products Regulatory Agency's (MHRA) October 2026 research, conducted with the GSK Vaccines Institute for Global Health, demonstrating the potential of a Group A Streptococcus (Strep A) vaccine using Generalised Modules for Membrane Antigens (GMMA).

The study investigated intranasal and sublingual administration and generated systemic and mucosal immune responses in mice.

The results provide an important preclinical development pathway, although clinical translation and commercial manufacturing remain outstanding.

For manufacturers, the next challenge involves aligning formulation stability, container design, delivery-device performance and aseptic fill-finish operations. 

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

You may also like